title: Can we stop ordering prostate-specific antigen screening tests?
authors.forename: Mitchell H
authors.initials: MH
authors.lastname: Katz
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001706:Biopsy; D003675:Defensive Medicine; D004180:Direct Service Costs; D055088:Early Detection of Cancer / Q000009:adverse effects / Q000191:economics / Q000379:methods; D006801:Humans; D007258:Informed Consent; D008297:Male; D011237:Predictive Value of Tests; D055656:Prescriptions; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000191:economics / Q000276:immunology / Q000517:prevention & control; D014481:United States; D019564:Unnecessary Procedures
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen